2024-04-012025-03-312025-03-31false05285665HEALTH ENTERPRISE EAST LIMITED2025-12-0374909falseiso4217:GBPxbrli:pure052856652024-03-31052856652025-03-31052856652024-04-012025-03-31052856652023-03-31052856652024-03-31052856652023-04-012024-03-3105285665bus:SmallEntities2024-04-012025-03-3105285665bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3105285665bus:FullAccounts2024-04-012025-03-3105285665bus:CompanyLimitedByGuarantee2024-04-012025-03-3105285665core:WithinOneYear2025-03-3105285665core:AfterOneYear2025-03-3105285665core:WithinOneYear2024-03-3105285665core:AfterOneYear2024-03-3105285665core:ShareCapital2025-03-3105285665core:SharePremium2025-03-3105285665core:RevaluationReserve2025-03-3105285665core:OtherReservesSubtotal2025-03-3105285665core:RetainedEarningsAccumulatedLosses2025-03-3105285665core:ShareCapital2024-03-3105285665core:SharePremium2024-03-3105285665core:RevaluationReserve2024-03-3105285665core:OtherReservesSubtotal2024-03-3105285665core:RetainedEarningsAccumulatedLosses2024-03-3105285665core:LandBuildings2025-03-3105285665core:PlantMachinery2025-03-3105285665core:Vehicles2025-03-3105285665core:FurnitureFittings2025-03-3105285665core:OfficeEquipment2025-03-3105285665core:NetGoodwill2025-03-3105285665core:IntangibleAssetsOtherThanGoodwill2025-03-3105285665core:ListedExchangeTraded2025-03-3105285665core:UnlistedNon-exchangeTraded2025-03-3105285665core:LandBuildings2024-03-3105285665core:PlantMachinery2024-03-3105285665core:Vehicles2024-03-3105285665core:FurnitureFittings2024-03-3105285665core:OfficeEquipment2024-03-3105285665core:NetGoodwill2024-03-3105285665core:IntangibleAssetsOtherThanGoodwill2024-03-3105285665core:ListedExchangeTraded2024-03-3105285665core:UnlistedNon-exchangeTraded2024-03-3105285665core:LandBuildings2024-04-012025-03-3105285665core:PlantMachinery2024-04-012025-03-3105285665core:Vehicles2024-04-012025-03-3105285665core:FurnitureFittings2024-04-012025-03-3105285665core:OfficeEquipment2024-04-012025-03-3105285665core:NetGoodwill2024-04-012025-03-3105285665core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3105285665core:ListedExchangeTraded2024-04-012025-03-3105285665core:UnlistedNon-exchangeTraded2024-04-012025-03-3105285665core:MoreThanFiveYears2024-04-012025-03-3105285665core:Non-currentFinancialInstruments2025-03-3105285665core:Non-currentFinancialInstruments2024-03-3105285665dpl:CostSales2024-04-012025-03-3105285665dpl:DistributionCosts2024-04-012025-03-3105285665core:LandBuildings2024-04-012025-03-3105285665core:PlantMachinery2024-04-012025-03-3105285665core:Vehicles2024-04-012025-03-3105285665core:FurnitureFittings2024-04-012025-03-3105285665core:OfficeEquipment2024-04-012025-03-3105285665dpl:AdministrativeExpenses2024-04-012025-03-3105285665core:NetGoodwill2024-04-012025-03-3105285665core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3105285665dpl:GroupUndertakings2024-04-012025-03-3105285665dpl:ParticipatingInterests2024-04-012025-03-3105285665dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3105285665core:ListedExchangeTraded2024-04-012025-03-3105285665dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3105285665core:UnlistedNon-exchangeTraded2024-04-012025-03-3105285665dpl:CostSales2023-04-012024-03-3105285665dpl:DistributionCosts2023-04-012024-03-3105285665core:LandBuildings2023-04-012024-03-3105285665core:PlantMachinery2023-04-012024-03-3105285665core:Vehicles2023-04-012024-03-3105285665core:FurnitureFittings2023-04-012024-03-3105285665core:OfficeEquipment2023-04-012024-03-3105285665dpl:AdministrativeExpenses2023-04-012024-03-3105285665core:NetGoodwill2023-04-012024-03-3105285665core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3105285665dpl:GroupUndertakings2023-04-012024-03-3105285665dpl:ParticipatingInterests2023-04-012024-03-3105285665dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3105285665core:ListedExchangeTraded2023-04-012024-03-3105285665dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3105285665core:UnlistedNon-exchangeTraded2023-04-012024-03-3105285665core:NetGoodwill2025-03-3105285665core:IntangibleAssetsOtherThanGoodwill2025-03-3105285665core:LandBuildings2025-03-3105285665core:PlantMachinery2025-03-3105285665core:Vehicles2025-03-3105285665core:FurnitureFittings2025-03-3105285665core:OfficeEquipment2025-03-3105285665core:AfterOneYear2025-03-3105285665core:WithinOneYear2025-03-3105285665core:ListedExchangeTraded2025-03-3105285665core:UnlistedNon-exchangeTraded2025-03-3105285665core:ShareCapital2025-03-3105285665core:SharePremium2025-03-3105285665core:RevaluationReserve2025-03-3105285665core:OtherReservesSubtotal2025-03-3105285665core:RetainedEarningsAccumulatedLosses2025-03-3105285665core:NetGoodwill2024-03-3105285665core:IntangibleAssetsOtherThanGoodwill2024-03-3105285665core:LandBuildings2024-03-3105285665core:PlantMachinery2024-03-3105285665core:Vehicles2024-03-3105285665core:FurnitureFittings2024-03-3105285665core:OfficeEquipment2024-03-3105285665core:AfterOneYear2024-03-3105285665core:WithinOneYear2024-03-3105285665core:ListedExchangeTraded2024-03-3105285665core:UnlistedNon-exchangeTraded2024-03-3105285665core:ShareCapital2024-03-3105285665core:SharePremium2024-03-3105285665core:RevaluationReserve2024-03-3105285665core:OtherReservesSubtotal2024-03-3105285665core:RetainedEarningsAccumulatedLosses2024-03-3105285665core:NetGoodwill2023-03-3105285665core:IntangibleAssetsOtherThanGoodwill2023-03-3105285665core:LandBuildings2023-03-3105285665core:PlantMachinery2023-03-3105285665core:Vehicles2023-03-3105285665core:FurnitureFittings2023-03-3105285665core:OfficeEquipment2023-03-3105285665core:AfterOneYear2023-03-3105285665core:WithinOneYear2023-03-3105285665core:ListedExchangeTraded2023-03-3105285665core:UnlistedNon-exchangeTraded2023-03-3105285665core:ShareCapital2023-03-3105285665core:SharePremium2023-03-3105285665core:RevaluationReserve2023-03-3105285665core:OtherReservesSubtotal2023-03-3105285665core:RetainedEarningsAccumulatedLosses2023-03-3105285665core:AfterOneYear2024-04-012025-03-3105285665core:WithinOneYear2024-04-012025-03-3105285665core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3105285665core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3105285665core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3105285665core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3105285665core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3105285665core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3105285665core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3105285665core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3105285665core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3105285665core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3105285665core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3105285665core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3105285665core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3105285665core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3105285665core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3105285665core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3105285665core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3105285665core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3105285665core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3105285665core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3105285665core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3105285665core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3105285665core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3105285665core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3105285665core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3105285665core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3105285665core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3105285665bus:Director12024-04-012025-03-3105285665bus:Director22024-04-012025-03-3105285665bus:Director32024-04-012025-03-3105285665bus:Director42024-04-012025-03-3105285665core:FurnitureFittingsToolsEquipment2024-03-3105285665core:FurnitureFittingsToolsEquipment2024-04-012025-03-3105285665core:FurnitureFittingsToolsEquipment2025-03-31

HEALTH ENTERPRISE EAST LIMITED

Registered Number
05285665
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

HEALTH ENTERPRISE EAST LIMITED
Company Information
for the year from 1 April 2024 to 31 March 2025

Directors

BLACKWOOD, Anne Dunlop, Dr
HUGHES, David Edward
JONES, Christopher Michael
MCDONNELL, Kevin Edward Martin

Company Secretary

JONES, Tara

Registered Address

St John's Innovation Centre
Cowley Road
Cambridge
CB4 0WS

Registered Number

05285665 (England and Wales)
HEALTH ENTERPRISE EAST LIMITED
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets36,94912,460
Investments499
6,95812,469
Current assets
Debtors570,88788,045
Cash at bank and on hand52,978161,174
123,865249,219
Creditors amounts falling due within one year6(253,197)(176,802)
Net current assets (liabilities)(129,332)72,417
Total assets less current liabilities(122,374)84,886
Creditors amounts falling due after one year7(15,000)(31,371)
Net assets(137,374)53,515
Capital and reserves
Profit and loss account(137,374)53,515
Reserves(137,374)53,515
The financial statements were approved and authorised for issue by the Board of Directors on 3 December 2025, and are signed on its behalf by:
BLACKWOOD, Anne Dunlop, Dr
Director
Registered Company No. 05285665
HEALTH ENTERPRISE EAST LIMITED
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by guarantee and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Going concern
In assessing the ability of the Company to continue as a going concern, the directors have prepared budgets for the period to 31 March 2026 and considered the trading period beyond this. The Company incurred a net loss of £190,888 (2024 – £258,938) during the year ended 31 March 2025. During the year, the cost base of the business was reduced, and the Company continues to explore further opportunities to improve profitability. Based upon their review, the directors have a reasonable expectation that the Company will have adequate resources available to finance its operations for a period of at least 12 months following the date of approval of these financial statements and, accordingly, have prepared the financial statements on a going concern basis.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Interest income
Interest income is recognised using the effective interest rate method.
Operating leases
Where, substantially, all the risks and rewards of ownership of the asset do not transfer from the lessor to the company, the lease is treated as an operating lease. Rentals payable under operating leases are charged to the profit and loss account on a straight-line basis over the period of the lease.
Defined contribution pension plan
The company operates a defined contribution pension plan for the benefit of its employees. Contributions are recognised as expenses as they become payable. Differences between contributions payable in the year and those actually paid are recognised as either prepayments or accruals in the balance sheet. The assets of the defined contribution pension scheme are held separately from those of the company in an independently administered fund.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Straight line (years)
Fixtures and fittings15
Office Equipment25
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
2.Average number of employees

20252024
Average number of employees during the year1214
3.Tangible fixed assets

Fixtures & fittings

Office Equipment

Total

£££
Cost or valuation
At 01 April 243,61843,54847,166
Disposals-(385)(385)
At 31 March 253,61843,16346,781
Depreciation and impairment
At 01 April 241,96532,74134,706
Charge for year4044,7225,126
At 31 March 252,36937,46339,832
Net book value
At 31 March 251,2495,7006,949
At 31 March 241,65310,80712,460
4.Fixed asset investments

Investments in groups1

Total

££
Cost or valuation
At 01 April 2499
At 31 March 2599
Net book value
At 31 March 2599
At 31 March 2499

Notes

1Investments in group undertakings and participating interests
5.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables57,39764,056
Other debtors4,3403,630
Prepayments and accrued income9,15020,359
Total70,88788,045
6.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables30,4798,036
Bank borrowings and overdrafts31,2725,882
Taxation and social security25,18138,713
Other creditors4,141-
Accrued liabilities and deferred income162,124124,171
Total253,197176,802
7.Creditors: amounts due after one year

2025

2024

££
Bank borrowings and overdrafts15,00031,371
Total15,00031,371